Octreotide Injection Clinical Trials

• Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
  ClinicalTrials.gov Identifier: NCT00274170 - Recruiting
  Migraine Headache
  
• Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003057 - Active, not recruiting
  Colon Cancer; Diarrhea; Rectal Cancer
  
• Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00008073 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Treatment with Octreotide in Patients with Lymphangioleiomyomatosis
  ClinicalTrials.gov Identifier: NCT00005906 - Recruiting
  Lymphangioleiomyomatosis; Lymphangiomyomatosis
  
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00075868 - Active, not recruiting
  Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
  
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
  ClinicalTrials.gov Identifier: NCT00003283 - Active, not recruiting
  recurrent malignant thymoma; invasive malignant thymoma
  
• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002779 - Active, not recruiting
  Lymphoma; Lymphoma, Small Lymphocytic; Lymphoma, Mantle-Cell; Waldenstrom's Macroglobulinemia; Lymphoma, Mucosa-Associated Lymphoid Tissue
  
• Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
  ClinicalTrials.gov Identifier: NCT00033605 - Active, not recruiting
  adult solid tumor; Diarrhea; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; male reproductive cancer
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Octreotide in Treating Patients With Cancer-Related Malignant Ascites
  ClinicalTrials.gov Identifier: NCT00182754 - Recruiting
  unspecified adult solid tumor, protocol specific; malignant ascites
  
• Preoperative Octreotide Treatment of Acromegaly
  ClinicalTrials.gov Identifier: NCT00521300 - Active, not recruiting
  Acromegaly
  
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00006269 - Active, not recruiting
  recurrent colon cancer; Diarrhea; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002864 - Active, not recruiting
  stage I breast cancer; stage III breast cancer; stage II breast cancer; Quality of Life
  
• Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00257426 - Active, not recruiting
  Liver Cancer
  
• Safety and Efficacy of Octreotide LAR in Treatment naïve Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00128232 - Completed
  Acromegaly
  
• Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049023 - Recruiting
  Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma
  
• Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00332696 - Active, not recruiting
  Peritoneal Neoplasms; Intestinal Obstruction; Carcinomatosis
  
• Preoperative Octreotide Treatment of Patients With Acromegaly
  ClinicalTrials.gov Identifier: NCT00241033 - Active, not recruiting
  Patients With Acromegaly
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227773 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
  
• Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
  ClinicalTrials.gov Identifier: NCT00170742 - Active, not recruiting
  Proliferative Diabetic Retinopathy
  
• Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
  ClinicalTrials.gov Identifier: NCT00332969 - Recruiting
  Thymoma
  
• Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
  ClinicalTrials.gov Identifier: NCT00372697 - Recruiting
  Acromegaly
  
• Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
  ClinicalTrials.gov Identifier: NCT00376064 - Recruiting
  Acromegaly
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00432068 - Recruiting
  Healthy
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
  ClinicalTrials.gov Identifier: NCT00145405 - Completed
  Acromegaly
  
• Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
  ClinicalTrials.gov Identifier: NCT00171873 - Recruiting
  Neuroendocrine Tumors
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
  ClinicalTrials.gov Identifier: NCT00412061 - Recruiting
  Carcinoid Tumor; Malignant Carcinoid Syndrome
  
• Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers
  ClinicalTrials.gov Identifier: NCT00222092 - Recruiting
  Post-ERCP Pancreatitis
  
• Vasoconstrictors as Alternatives to Albumin after LVP (Large-Volume Paracentesis) in Cirrhosis
  ClinicalTrials.gov Identifier: NCT00108355 - Recruiting
  Cirrhosis; Ascites
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Octreotide in Severe Polycystic Liver Disease
  ClinicalTrials.gov Identifier: NCT00426153 - Recruiting
  Polycystic Kidney, Autosomal Dominant; Hepatomegaly; Liver Diseases; Kidney, Polycystic; Abdominal Pain
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Octreotide Therapy in Children With Prader-Willi Syndrome (PWS)
  ClinicalTrials.gov Identifier: NCT00399893 - Recruiting
  Prader-Willi Syndrome
  
• Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
  ClinicalTrials.gov Identifier: NCT00463983 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00006368 - Active, not recruiting
  Lung Cancer; Melanoma; Lymphoma; Brain Tumor; Breast Cancer
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
  ClinicalTrials.gov Identifier: NCT00004327 - Completed
  Hereditary Hemorrhagic Telangiectasia; Ectasia
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
  ClinicalTrials.gov Identifier: NCT00569127 - Not yet recruiting
  Head and Neck Cancer; Islet Cell Tumor; Neuroendocrine Carcinoma of the Skin
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• Evaluation of Octreotide LAR in Prevention of Chemotherapy-Induced Diarrhea
  ClinicalTrials.gov Identifier: NCT00582426 - Not yet recruiting
  Chemotherapy-Induced Diarrhea
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
  ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
  Lipoma
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
  ClinicalTrials.gov Identifier: NCT00307606 - Recruiting
  Breast Neoplasms; Mastectomy
  
• To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients when given with an Experimental Injection Catheter
  ClinicalTrials.gov Identifier: NCT00090714 - Active, not recruiting
  Angina Pectoris
  
• Safety and Effectiveness of SeeMore (EVP 1001-1 Injection) for MRI in Heart Patients
  ClinicalTrials.gov Identifier: NCT00340925 - Recruiting
  Myocardial Infarction
  
• Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
  ClinicalTrials.gov Identifier: NCT00575744 - Recruiting
  Breast Cancer
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00079742 - Active, not recruiting
  Cystic Fibrosis
  
• Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00438477 - Active, not recruiting
  Breast Cancer
  
• Comparison Study of Operation and Percutaneous Ethanol Injection Therapy for Small, Solitary HCC
  ClinicalTrials.gov Identifier: NCT00357422 - Recruiting
  Hepatocellular Carcinoma
  
• Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
  ClinicalTrials.gov Identifier: NCT00357474 - Recruiting
  Hepatocellular Carcinoma
  
• Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00364143 - Recruiting
  Cancer
  
• The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.
  ClinicalTrials.gov Identifier: NCT00407290 - Recruiting
  Pregnancy; Vaginal Delivery
  
• Sub-Tenon’s Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00431028 - Recruiting
  Inflammation; Bacterial Infections
  
• This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
  ClinicalTrials.gov Identifier: NCT00479596 - Recruiting
  Overactive Bladder
  
• Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00064610 - Active, not recruiting
  Prostatic Neoplasms
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis
  ClinicalTrials.gov Identifier: NCT00314366 - Recruiting
  Coronary Artery Disease
  
• Corticosteroid Injection for Common Upper Extremity Problems
  ClinicalTrials.gov Identifier: NCT00438672 - Recruiting
  Lateral Elbow Pain; deQuervain’s Tendonitis; CMC Arthritis
  
• Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00461955 - Recruiting
  Multiple Myeloma
  
• A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
  ClinicalTrials.gov Identifier: NCT00536016 - Recruiting
  Macular Degeneration
  
• Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00144820 - Active, not recruiting
  Osteoarthritis, Knee